Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers

In the 115 years since the discovery of Alzheimer’s disease (AD), our knowledge, diagnosis, and therapeutics have significantly improved. Biomarkers are the primary tools for clinical research, diagnostics, and therapeutic monitoring in clinical trials. They provide much insightful information, and...

Full description

Saved in:
Bibliographic Details
Main Authors: Sakulrat Mankhong, Sujin Kim, Seongju Lee, Hyo-Bum Kwak, Dong-Ho Park, Kyung-Lim Joa, Ju-Hee Kang
Format: Artigo
Language:Inglês
Published: MDPI AG 2022-04-01
Series:Biomedicines
Subjects:
Alzheimer’s biomarker
cerebrospinal fluid
blood-based biomarker
clinical trial
amyloid-beta
tau
Online Access:https://www.mdpi.com/2227-9059/10/4/850
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items